首页 > 最新文献

Nutrition reviews最新文献

英文 中文
The Frequently Used Industrial Food Process Additive, Microbial Transglutaminase: Boon or Bane. 常用的工业食品加工添加剂--微生物转谷氨酰胺酶:是福还是祸?
IF 5.9 2区 医学 Q1 NUTRITION & DIETETICS Pub Date : 2024-07-03 DOI: 10.1093/nutrit/nuae087
Aaron Lerner, Carina Benzvi, Aristo Vojdani

Microbial transglutaminase (mTG) is a frequently consumed processed food additive, and use of its cross-linked complexes is expanding rapidly. It was designated as a processing aid and was granted the generally recognized as safe (GRAS) classification decades ago, thus avoiding thorough assessment according to current criteria of toxicity and public health safety. In contrast to the manufacturer's declarations and claims, mTG and/or its transamidated complexes are proinflammatory, immunogenic, allergenic, pathogenic, and potentially toxic, hence raising concerns for public health. Being a member of the transglutaminase family and functionally imitating the tissue transglutaminase, mTG was recently identified as a potential inducer of celiac disease. Microbial transglutaminase and its docked complexes have numerous detrimental effects. Those harmful aspects are denied by the manufacturers, who claim the enzyme is deactivated when heated or by gastric acidity, and that its covalently linked isopeptide bonds are safe. The present narrative review describes the potential side effects of mTG, highlighting its thermostability and activity over a broad pH range, thus, challenging the manufacturers' and distributers' safety claims. The national food regulatory authorities and the scientific community are urged to reevaluate mTG's GRAS status, prioritizing public health protection against the possible risks associated with this enzyme and its health-damaging consequences.

微生物转谷氨酰胺酶(mTG)是一种经常食用的加工食品添加剂,其交联复合物的使用正在迅速扩大。几十年前,它就被指定为加工助剂,并被授予公认安全(GRAS)分类,从而避免了根据当前的毒性和公共卫生安全标准进行彻底评估。与生产商的声明和声称相反,mTG 和/或其转氨复合物具有促炎、免疫原性、致敏性、致病性和潜在毒性,因此引起了公众健康的关注。mTG 是转谷氨酰胺酶家族的成员,在功能上与组织转谷氨酰胺酶相似,最近被确认为乳糜泻的潜在诱导物。微生物转谷氨酰胺酶及其对接复合物有许多有害影响。生产商否认了这些有害影响,声称这种酶在加热或胃酸作用下会失活,而且其共价连接的异肽键是安全的。本综述描述了 mTG 的潜在副作用,强调了它在广泛 pH 值范围内的热稳定性和活性,从而对制造商和经销商的安全声明提出质疑。敦促各国食品监管机构和科学界重新评估 mTG 的 GRAS 地位,优先考虑保护公众健康,防范这种酶可能带来的风险及其损害健康的后果。
{"title":"The Frequently Used Industrial Food Process Additive, Microbial Transglutaminase: Boon or Bane.","authors":"Aaron Lerner, Carina Benzvi, Aristo Vojdani","doi":"10.1093/nutrit/nuae087","DOIUrl":"https://doi.org/10.1093/nutrit/nuae087","url":null,"abstract":"<p><p>Microbial transglutaminase (mTG) is a frequently consumed processed food additive, and use of its cross-linked complexes is expanding rapidly. It was designated as a processing aid and was granted the generally recognized as safe (GRAS) classification decades ago, thus avoiding thorough assessment according to current criteria of toxicity and public health safety. In contrast to the manufacturer's declarations and claims, mTG and/or its transamidated complexes are proinflammatory, immunogenic, allergenic, pathogenic, and potentially toxic, hence raising concerns for public health. Being a member of the transglutaminase family and functionally imitating the tissue transglutaminase, mTG was recently identified as a potential inducer of celiac disease. Microbial transglutaminase and its docked complexes have numerous detrimental effects. Those harmful aspects are denied by the manufacturers, who claim the enzyme is deactivated when heated or by gastric acidity, and that its covalently linked isopeptide bonds are safe. The present narrative review describes the potential side effects of mTG, highlighting its thermostability and activity over a broad pH range, thus, challenging the manufacturers' and distributers' safety claims. The national food regulatory authorities and the scientific community are urged to reevaluate mTG's GRAS status, prioritizing public health protection against the possible risks associated with this enzyme and its health-damaging consequences.</p>","PeriodicalId":19469,"journal":{"name":"Nutrition reviews","volume":null,"pages":null},"PeriodicalIF":5.9,"publicationDate":"2024-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141498594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unraveling the Health Benefits and Mechanisms of Time-Restricted Feeding: Beyond Caloric Restriction. 揭示限时喂养的健康益处和机制:超越热量限制。
IF 5.9 2区 医学 Q1 NUTRITION & DIETETICS Pub Date : 2024-07-02 DOI: 10.1093/nutrit/nuae074
Ruhan Wang, Yuxiao Liao, Yan Deng, Rong Shuang

Time-restricted feeding (TRF) is a lifestyle intervention that aims to maintain a consistent daily cycle of feeding and fasting to support robust circadian rhythms. Recently, it has gained scientific, medical, and public attention due to its potential to enhance body composition, extend lifespan, and improve overall health, as well as induce autophagy and alleviate symptoms of diseases like cardiovascular diseases, type 2 diabetes, neurodegenerative diseases, cancer, and ischemic injury. However, there is still considerable debate on the primary factors that contribute to the health benefits of TRF. Despite not imposing strict limitations on calorie intake, TRF consistently led to reductions in calorie intake. Therefore, while some studies suggest that the health benefits of TRF are primarily due to caloric restriction (CR), others argue that the key advantages of TRF arise not only from CR but also from factors like the duration of fasting, the timing of the feeding period, and alignment with circadian rhythms. To elucidate the roles and mechanisms of TRF beyond CR, this review incorporates TRF studies that did not use CR, as well as TRF studies with equivalent energy intake to CR, which addresses the previous lack of comprehensive research on TRF without CR and provides a framework for future research directions.

限时进食(TRF)是一种生活方式干预措施,旨在保持每天进食和禁食的一致周期,以支持稳健的昼夜节律。近来,限时进食因其具有增强体质、延长寿命、改善整体健康、诱导自噬和缓解心血管疾病、2 型糖尿病、神经退行性疾病、癌症和缺血性损伤等疾病症状的潜力而受到科学界、医学界和公众的关注。然而,关于 TRF 对健康有益的主要因素仍存在很大争议。尽管 TRF 没有严格限制卡路里的摄入量,但 TRF 始终导致卡路里摄入量的减少。因此,一些研究表明,TRF 对健康的益处主要来自于热量限制(CR),而另一些研究则认为,TRF 的主要优势不仅来自于热量限制,还来自于禁食时间、进食时间以及与昼夜节律的一致性等因素。为了阐明 TRF 在热量限制之外的作用和机制,本综述纳入了未使用热量限制的 TRF 研究,以及与热量限制同等能量摄入的 TRF 研究,从而解决了以往缺乏不使用热量限制的 TRF 综合研究的问题,并为未来的研究方向提供了一个框架。
{"title":"Unraveling the Health Benefits and Mechanisms of Time-Restricted Feeding: Beyond Caloric Restriction.","authors":"Ruhan Wang, Yuxiao Liao, Yan Deng, Rong Shuang","doi":"10.1093/nutrit/nuae074","DOIUrl":"https://doi.org/10.1093/nutrit/nuae074","url":null,"abstract":"<p><p>Time-restricted feeding (TRF) is a lifestyle intervention that aims to maintain a consistent daily cycle of feeding and fasting to support robust circadian rhythms. Recently, it has gained scientific, medical, and public attention due to its potential to enhance body composition, extend lifespan, and improve overall health, as well as induce autophagy and alleviate symptoms of diseases like cardiovascular diseases, type 2 diabetes, neurodegenerative diseases, cancer, and ischemic injury. However, there is still considerable debate on the primary factors that contribute to the health benefits of TRF. Despite not imposing strict limitations on calorie intake, TRF consistently led to reductions in calorie intake. Therefore, while some studies suggest that the health benefits of TRF are primarily due to caloric restriction (CR), others argue that the key advantages of TRF arise not only from CR but also from factors like the duration of fasting, the timing of the feeding period, and alignment with circadian rhythms. To elucidate the roles and mechanisms of TRF beyond CR, this review incorporates TRF studies that did not use CR, as well as TRF studies with equivalent energy intake to CR, which addresses the previous lack of comprehensive research on TRF without CR and provides a framework for future research directions.</p>","PeriodicalId":19469,"journal":{"name":"Nutrition reviews","volume":null,"pages":null},"PeriodicalIF":5.9,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141492859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adherence to Mediterranean Diet and Health Outcomes in Adolescents: An Umbrella Review. 坚持地中海饮食与青少年的健康结果:综述。
IF 5.9 2区 医学 Q1 NUTRITION & DIETETICS Pub Date : 2024-07-02 DOI: 10.1093/nutrit/nuae085
Annalisa Di Nucci, Marco Silano, Erica Cardamone

Context: Proper nutrition represents 1 of the domains of adolescents' well-being. In this context, the Mediterranean diet (MD), as a healthy, traditional, and sustainable dietary pattern, plays a crucial role in promoting adequate growth and preventing chronic noncommunicable diseases.

Objective: The currently available evidence on the effects of adherence to the MD (AMD) in association with several physical health outcomes in adolescence is summarized in this review.

Data sources: Five electronic databases were searched.

Study selection: Systematic reviews with or without meta-analysis of observational studies and randomized clinical trials, published in English during 2013-2022, and that assessed the health impact of AMD among adolescents were eligible.

Data extraction: Details on study design, methods, population, assessment of dietary patterns, health outcomes, and main results were extracted.

Results: The search yielded 59 references after removal of duplicates. Applying PICOS criteria, 4 systematic reviews and 3 meta-analyses ultimately were included in this review. The AMD was evaluated in association with overweight/obesity and adiposity in 2 studies, musculoskeletal health in another 2, inflammation in 1 study, and cardiometabolic health in 1 study. The seventh review examined all mentioned health outcomes (overweight and obesity, musculoskeletal health, inflammation, and cardiometabolic health) in relation to AMD.

Conclusions: Overall, this umbrella review showed limited evidence and a lack of consistency about the relation between AMD and health outcomes of interest in adolescence, indicating the need for more studies to better understand it.

Systemic review registration: PROSPERO registration no. CRD42023428712.

背景适当的营养是青少年福祉的一个方面。在此背景下,地中海饮食(Mediterranean diet,MD)作为一种健康、传统和可持续的饮食模式,在促进适当发育和预防慢性非传染性疾病方面发挥着至关重要的作用:本综述总结了关于坚持地中海饮食(AMD)对青少年身体健康的影响的现有证据:数据来源:检索了五个电子数据库:研究选择:2013-2022 年间以英文发表的、评估 AMD 对青少年健康影响的观察性研究和随机临床试验的系统综述,无论是否进行了荟萃分析:提取研究设计、方法、人群、饮食模式评估、健康结果和主要结果的详细信息:结果:去除重复内容后,共检索到 59 篇参考文献。根据 PICOS 标准,本综述最终纳入了 4 篇系统综述和 3 篇荟萃分析。其中 2 项研究评估了 AMD 与超重/肥胖和脂肪率的关系,另外 2 项研究评估了肌肉骨骼健康,1 项研究评估了炎症,1 项研究评估了心脏代谢健康。第七篇综述研究了与 AMD 有关的所有上述健康结果(超重和肥胖、肌肉骨骼健康、炎症和心脏代谢健康):总体而言,这篇综述显示,关于 AMD 与青春期相关健康结果之间关系的证据有限且缺乏一致性,这表明需要进行更多的研究来更好地了解这一关系:系统综述注册:PROSPERO 注册号CRD42023428712。
{"title":"Adherence to Mediterranean Diet and Health Outcomes in Adolescents: An Umbrella Review.","authors":"Annalisa Di Nucci, Marco Silano, Erica Cardamone","doi":"10.1093/nutrit/nuae085","DOIUrl":"https://doi.org/10.1093/nutrit/nuae085","url":null,"abstract":"<p><strong>Context: </strong>Proper nutrition represents 1 of the domains of adolescents' well-being. In this context, the Mediterranean diet (MD), as a healthy, traditional, and sustainable dietary pattern, plays a crucial role in promoting adequate growth and preventing chronic noncommunicable diseases.</p><p><strong>Objective: </strong>The currently available evidence on the effects of adherence to the MD (AMD) in association with several physical health outcomes in adolescence is summarized in this review.</p><p><strong>Data sources: </strong>Five electronic databases were searched.</p><p><strong>Study selection: </strong>Systematic reviews with or without meta-analysis of observational studies and randomized clinical trials, published in English during 2013-2022, and that assessed the health impact of AMD among adolescents were eligible.</p><p><strong>Data extraction: </strong>Details on study design, methods, population, assessment of dietary patterns, health outcomes, and main results were extracted.</p><p><strong>Results: </strong>The search yielded 59 references after removal of duplicates. Applying PICOS criteria, 4 systematic reviews and 3 meta-analyses ultimately were included in this review. The AMD was evaluated in association with overweight/obesity and adiposity in 2 studies, musculoskeletal health in another 2, inflammation in 1 study, and cardiometabolic health in 1 study. The seventh review examined all mentioned health outcomes (overweight and obesity, musculoskeletal health, inflammation, and cardiometabolic health) in relation to AMD.</p><p><strong>Conclusions: </strong>Overall, this umbrella review showed limited evidence and a lack of consistency about the relation between AMD and health outcomes of interest in adolescence, indicating the need for more studies to better understand it.</p><p><strong>Systemic review registration: </strong>PROSPERO registration no. CRD42023428712.</p>","PeriodicalId":19469,"journal":{"name":"Nutrition reviews","volume":null,"pages":null},"PeriodicalIF":5.9,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141492858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effects of Vitamin D Supplementation During Pregnancy on Maternal, Neonatal, and Infant Health: A Systematic Review and Meta-analysis. 孕期补充维生素 D 对孕产妇、新生儿和婴儿健康的影响:系统回顾与元分析》。
IF 5.9 2区 医学 Q1 NUTRITION & DIETETICS Pub Date : 2024-07-01 DOI: 10.1093/nutrit/nuae065
Wen-Chien Yang, Ramaa Chitale, Karen M O'Callaghan, Christopher R Sudfeld, Emily R Smith

Context: Previous research linked vitamin D deficiency in pregnancy to adverse pregnancy outcomes.

Objective: Update a 2017 systematic review and meta-analysis of randomized controlled trials (RCTs) on the effect of vitamin D supplementation during pregnancy, identify sources of heterogeneity between trials, and describe evidence gaps precluding a clinical recommendation.

Data sources: The MEDLINE, PubMed, Europe PMC, Scopus, Cochrane Database of Systematic Reviews, Web of Science, and CINAHL databases were searched. Articles were included that reported on RCTs that included pregnant women given vitamin D supplements as compared with placebo, no intervention, or active control (≤600 IU d-1). Risk ratios (RRs) and mean differences were pooled for 38 maternal, birth, and infant outcomes, using random effects models. Subgroup analyses examined effect heterogeneity. The Cochrane risk of bias tool was used.

Data extraction: Included articles reported on a total of 66 trials (n = 17 276 participants).

Data analysis: The median vitamin D supplementation dose was 2000 IU d-1 (range: 400-60 000); 37 trials used placebo. Antenatal vitamin D supplementation had no effect on the risk of preeclampsia (RR, 0.81 [95% CI, 0.43-1.53]; n = 6 trials and 1483 participants), potentially protected against gestational diabetes mellitus (RR, 0.65 [95% CI, 0.49-0.86; n = 12 trials and 1992 participants), and increased infant birth weight by 53 g (95% CI, 16-90; n = 40 trials and 9954 participants). No effect of vitamin D on the risk of preterm birth, small-for-gestational age, or low birth weight infants was found. A total of 25 trials had at least 1 domain at high risk of bias.

Conclusion: Additional studies among the general pregnant population are not needed, given the many existing trials. Instead, high-quality RCTs among populations with low vitamin D status or at greater risk of key outcomes are needed. Benefits of supplementation in pregnancy remain uncertain because current evidence has high heterogeneity, including variation in study context, baseline and achieved end-line 25-hydroxyvitamin D level, and studies with high risk of bias.

Systematic review registration: PROSPERO registration no. CRD42022350057.

背景:以往的研究表明,孕期维生素D缺乏与不良妊娠结局有关:更新2017年关于孕期补充维生素D效果的随机对照试验(RCTs)的系统综述和荟萃分析,确定试验间异质性的来源,并描述排除临床建议的证据缺口:数据来源:检索了 MEDLINE、PubMed、Europe PMC、Scopus、Cochrane 系统综述数据库、Web of Science 和 CINAHL 数据库。纳入的文章报告了孕妇服用维生素 D 补充剂与安慰剂、无干预或活性对照(≤600 IU d-1)进行比较的 RCT。采用随机效应模型对 38 种母体、出生和婴儿结果的风险比 (RR) 和平均差异进行了汇总。亚组分析检验了效应异质性。数据提取采用了 Cochrane 偏倚风险工具:数据分析:维生素 D 补充剂剂量的中位数为 2000 IU d-1(范围:400-60 000);37 项试验使用了安慰剂。产前补充维生素 D 对先兆子痫的风险没有影响(RR,0.81 [95% CI,0.43-1.53];n = 6 项试验和 1483 名参与者),可预防妊娠糖尿病(RR,0.65 [95% CI,0.49-0.86;n = 12 项试验和 1992 名参与者),婴儿出生体重增加 53 克(95% CI,16-90;n = 40 项试验和 9954 名参与者)。没有发现维生素 D 对早产儿、小于胎龄儿或低出生体重儿的风险有任何影响。共有 25 项试验至少有一个领域存在高偏倚风险:结论:鉴于现有的许多试验,不需要在普通孕妇人群中开展更多的研究。结论:鉴于现有的许多试验,不需要在普通孕妇人群中进行更多的研究,而是需要在维生素 D 水平较低或主要结果风险较高的人群中进行高质量的 RCT 研究。妊娠期补充维生素 D 的益处仍不确定,因为目前的证据存在高度异质性,包括研究背景、基线和达到的终点 25- 羟基维生素 D 水平的差异,以及存在高偏倚风险的研究:系统综述注册:PROSPERO 注册号系统综述注册:PROSPERO 注册编号:CRD42022350057。
{"title":"The Effects of Vitamin D Supplementation During Pregnancy on Maternal, Neonatal, and Infant Health: A Systematic Review and Meta-analysis.","authors":"Wen-Chien Yang, Ramaa Chitale, Karen M O'Callaghan, Christopher R Sudfeld, Emily R Smith","doi":"10.1093/nutrit/nuae065","DOIUrl":"https://doi.org/10.1093/nutrit/nuae065","url":null,"abstract":"<p><strong>Context: </strong>Previous research linked vitamin D deficiency in pregnancy to adverse pregnancy outcomes.</p><p><strong>Objective: </strong>Update a 2017 systematic review and meta-analysis of randomized controlled trials (RCTs) on the effect of vitamin D supplementation during pregnancy, identify sources of heterogeneity between trials, and describe evidence gaps precluding a clinical recommendation.</p><p><strong>Data sources: </strong>The MEDLINE, PubMed, Europe PMC, Scopus, Cochrane Database of Systematic Reviews, Web of Science, and CINAHL databases were searched. Articles were included that reported on RCTs that included pregnant women given vitamin D supplements as compared with placebo, no intervention, or active control (≤600 IU d-1). Risk ratios (RRs) and mean differences were pooled for 38 maternal, birth, and infant outcomes, using random effects models. Subgroup analyses examined effect heterogeneity. The Cochrane risk of bias tool was used.</p><p><strong>Data extraction: </strong>Included articles reported on a total of 66 trials (n = 17 276 participants).</p><p><strong>Data analysis: </strong>The median vitamin D supplementation dose was 2000 IU d-1 (range: 400-60 000); 37 trials used placebo. Antenatal vitamin D supplementation had no effect on the risk of preeclampsia (RR, 0.81 [95% CI, 0.43-1.53]; n = 6 trials and 1483 participants), potentially protected against gestational diabetes mellitus (RR, 0.65 [95% CI, 0.49-0.86; n = 12 trials and 1992 participants), and increased infant birth weight by 53 g (95% CI, 16-90; n = 40 trials and 9954 participants). No effect of vitamin D on the risk of preterm birth, small-for-gestational age, or low birth weight infants was found. A total of 25 trials had at least 1 domain at high risk of bias.</p><p><strong>Conclusion: </strong>Additional studies among the general pregnant population are not needed, given the many existing trials. Instead, high-quality RCTs among populations with low vitamin D status or at greater risk of key outcomes are needed. Benefits of supplementation in pregnancy remain uncertain because current evidence has high heterogeneity, including variation in study context, baseline and achieved end-line 25-hydroxyvitamin D level, and studies with high risk of bias.</p><p><strong>Systematic review registration: </strong>PROSPERO registration no. CRD42022350057.</p>","PeriodicalId":19469,"journal":{"name":"Nutrition reviews","volume":null,"pages":null},"PeriodicalIF":5.9,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141477092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Folate Biomarkers, Folate Intake, and Risk of Death From All Causes, Cardiovascular Disease, and Cancer: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies. 叶酸生物标志物、叶酸摄入量与各种原因、心血管疾病和癌症的死亡风险:前瞻性队列研究的系统回顾与剂量反应元分析》。
IF 5.9 2区 医学 Q1 NUTRITION & DIETETICS Pub Date : 2024-07-01 DOI: 10.1093/nutrit/nuae077
Melika Fallah, Maryam Karim Dehnavi, Keyhan Lotfi, Azadeh Aminianfar, Leila Azadbakht, Ahmad Esmaillzadeh

Context: Existing evidence on the relation between folate intake and biomarkers with mortality risk is controversial.

Objective: Previous cohort studies were examined regarding folate intake and biomarkers in relation to risk of all-cause, cardiovascular disease- (CVD), and cancer-related mortality through a systematic review and meta-analysis.

Data sources: A systematic search was performed of the PubMed, Scopus, and ISI Web of Science databases up to July 2023.

Data extraction: Prospective cohort studies examining the association of folate biomarkers (in serum, plasma, red blood cells) and intake with risk of all-cause, CVD-, and cancer-related mortality were considered. A random-effects model was applied to combine study-specific risk estimates. Dose-response relations were assessed by 1-stage weighted mixed-effects meta-analysis.

Data analysis: A total of 25 cohorts with 423 304 participants, 36 558 all-cause, 12 662 CVD-, and 2426 cancer-related deaths were included. No significant association was observed between the highest levels of folate biomarkers and all-cause mortality risk (hazard ratio [HR], 0.91; 95% CI, 0.77-1.06; n = 17; I2 = 89.4%; P < .001), CVD-related mortality risk (HR, 0.97; 95% CI, 0.87-1.06; n = 11; I2 = 0.0%; P = .57), and cancer-related mortality risk (HR, 0.85; 95% CI, 0.69-1.05; n = 6; I2 = 57.8%; P = .04) compared with the lowest. Furthermore, each 10 nmol/L increase was marginally related to a 12% reduced all-cause mortality risk but not to CVD- and cancer-related mortality risk. A significant inverse association was found between highest intake of dietary folate and the lowest, and risk of all-cause (HR, 0.87; 95% CI, 0.78-0.96; n = 3; I2 = 63.6%; P = .06) and CVD (HR, 0.77; 95% CI, 0.57-0.93; n = 4; I2 = 80.2%; P = .002) mortality.

Conclusions: This meta-analysis revealed a significant inverse relation between dietary folate intake and risk of all-cause and CVD mortality. Such an association was not found in the case of folate biomarkers. Further prospective studies are warranted to confirm these findings.

Systematic review registration: PROSPERO registration no. CRD42023401700.

背景:关于叶酸摄入量和生物标志物与死亡风险之间关系的现有证据存在争议:通过系统综述和荟萃分析,研究了以往队列研究中叶酸摄入量和生物标志物与全因、心血管疾病(CVD)和癌症相关死亡率风险的关系:对截至 2023 年 7 月的 PubMed、Scopus 和 ISI Web of Science 数据库进行了系统检索:前瞻性队列研究考察了叶酸生物标志物(血清、血浆、红细胞中)和摄入量与全因、心血管疾病和癌症相关死亡风险的关系。采用随机效应模型来合并研究的特定风险估计值。剂量-反应关系通过一级加权混合效应荟萃分析进行评估:共纳入了 25 个队列,423 304 名参与者,36 558 例全因死亡、12 662 例心血管疾病死亡和 2426 例癌症相关死亡。未观察到叶酸生物标志物的最高水平与全因死亡风险之间存在明显关联(危险比 [HR],0.91;95% CI,0.77-1.06;n = 17;I2 = 89.4%;P 结论:该荟萃分析显示,叶酸生物标志物的最高水平与全因死亡风险之间存在明显关联:这项荟萃分析表明,膳食叶酸摄入量与全因和心血管疾病死亡风险之间存在显著的反向关系。而叶酸生物标志物则没有发现这种关联。有必要开展进一步的前瞻性研究来证实这些发现:系统综述注册:PROSPERO 注册号CRD42023401700。
{"title":"Folate Biomarkers, Folate Intake, and Risk of Death From All Causes, Cardiovascular Disease, and Cancer: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies.","authors":"Melika Fallah, Maryam Karim Dehnavi, Keyhan Lotfi, Azadeh Aminianfar, Leila Azadbakht, Ahmad Esmaillzadeh","doi":"10.1093/nutrit/nuae077","DOIUrl":"https://doi.org/10.1093/nutrit/nuae077","url":null,"abstract":"<p><strong>Context: </strong>Existing evidence on the relation between folate intake and biomarkers with mortality risk is controversial.</p><p><strong>Objective: </strong>Previous cohort studies were examined regarding folate intake and biomarkers in relation to risk of all-cause, cardiovascular disease- (CVD), and cancer-related mortality through a systematic review and meta-analysis.</p><p><strong>Data sources: </strong>A systematic search was performed of the PubMed, Scopus, and ISI Web of Science databases up to July 2023.</p><p><strong>Data extraction: </strong>Prospective cohort studies examining the association of folate biomarkers (in serum, plasma, red blood cells) and intake with risk of all-cause, CVD-, and cancer-related mortality were considered. A random-effects model was applied to combine study-specific risk estimates. Dose-response relations were assessed by 1-stage weighted mixed-effects meta-analysis.</p><p><strong>Data analysis: </strong>A total of 25 cohorts with 423 304 participants, 36 558 all-cause, 12 662 CVD-, and 2426 cancer-related deaths were included. No significant association was observed between the highest levels of folate biomarkers and all-cause mortality risk (hazard ratio [HR], 0.91; 95% CI, 0.77-1.06; n = 17; I2 = 89.4%; P < .001), CVD-related mortality risk (HR, 0.97; 95% CI, 0.87-1.06; n = 11; I2 = 0.0%; P = .57), and cancer-related mortality risk (HR, 0.85; 95% CI, 0.69-1.05; n = 6; I2 = 57.8%; P = .04) compared with the lowest. Furthermore, each 10 nmol/L increase was marginally related to a 12% reduced all-cause mortality risk but not to CVD- and cancer-related mortality risk. A significant inverse association was found between highest intake of dietary folate and the lowest, and risk of all-cause (HR, 0.87; 95% CI, 0.78-0.96; n = 3; I2 = 63.6%; P = .06) and CVD (HR, 0.77; 95% CI, 0.57-0.93; n = 4; I2 = 80.2%; P = .002) mortality.</p><p><strong>Conclusions: </strong>This meta-analysis revealed a significant inverse relation between dietary folate intake and risk of all-cause and CVD mortality. Such an association was not found in the case of folate biomarkers. Further prospective studies are warranted to confirm these findings.</p><p><strong>Systematic review registration: </strong>PROSPERO registration no. CRD42023401700.</p>","PeriodicalId":19469,"journal":{"name":"Nutrition reviews","volume":null,"pages":null},"PeriodicalIF":5.9,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141477091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multicriteria Measures to Assess the Sustainability of Diets: A Systematic Review. 评估膳食可持续性的多重标准措施:系统综述。
IF 5.9 2区 医学 Q1 NUTRITION & DIETETICS Pub Date : 2024-06-28 DOI: 10.1093/nutrit/nuae081
Mariana Rei, Alexandra Costa, Sofia Sosa, Sofia da Costa, Duarte Torres, Colin Sage, Sara Rodrigues

Context: Assessing the overall sustainability of a diet is a challenging undertaking requiring a holistic approach capable of addressing the multicriteria nature of this concept.

Objective: The aim was to identify and summarize the multicriteria measures used to assess the sustainability characteristics of diets reported at the individual level by healthy adults.

Data sources: Articles were identified via PubMed, Scopus, and Web of Science. The search strategy consisted of key words and MeSH terms, and was concluded in September 2022, covering references in English, Spanish, and Portuguese.

Data extraction: This systematic review followed the PRISMA guidelines. The search identified 5663 references, from which 1794 were duplicates. Two reviewers independently screened the titles and abstracts of each of the 3869 records and the full-text of the 144 references selected. Of these, 7 studies met the inclusion criteria.

Data analysis: A total of 6 multicriteria measures were identified: 3 different Sustainable Diet Indices, the Quality Environmental Costs of Diet, the Quality Financial Costs of Diet, and the Environmental Impact of Diet. All of these incorporated a health/nutrition dimension, while the environmental and economic dimensions were the second and the third most integrated, respectively. A sociocultural sustainability dimension was included in only 1 of the measures.

Conclusion: Despite some methodological concerns in the development and validation process of the identified measures, their inclusion is considered indispensable in assessing the transition towards sustainable diets in future studies.

Systematic review registration: PROSPERO registration no. CRD42022358824.

背景:评估膳食的整体可持续性是一项具有挑战性的工作,需要一种能够解决这一概念的多标准性质的整体方法:数据来源:通过 PubMed、Scopus 和 Web 查找文章:数据来源:通过 PubMed、Scopus 和 Web of Science 查找文章。搜索策略包括关键词和 MeSH 术语,搜索于 2022 年 9 月结束,涵盖英语、西班牙语和葡萄牙语的参考文献:本系统性综述遵循 PRISMA 指南。检索共发现 5663 篇参考文献,其中 1794 篇为重复。两名审稿人分别独立筛选了 3869 条记录的标题和摘要,以及所选 144 篇参考文献的全文。其中,7 项研究符合纳入标准:数据分析:共确定了 6 项多重标准衡量方法:数据分析:共确定了 6 项多标准衡量方法:3 种不同的可持续膳食指数、膳食的质量环境成本、膳食的质量财务成本和膳食的环境影响。所有这些都包含了健康/营养维度,而环境和经济维度分别是第二和第三大综合维度。只有一项措施包含了社会文化可持续性维度:尽管在制定和验证所确定的衡量标准的过程中存在一些方法上的问题,但在未来的研究中,纳入这些衡量标准对于评估向可持续膳食的过渡是不可或缺的:系统综述注册:PROSPERO 注册号CRD42022358824。
{"title":"Multicriteria Measures to Assess the Sustainability of Diets: A Systematic Review.","authors":"Mariana Rei, Alexandra Costa, Sofia Sosa, Sofia da Costa, Duarte Torres, Colin Sage, Sara Rodrigues","doi":"10.1093/nutrit/nuae081","DOIUrl":"https://doi.org/10.1093/nutrit/nuae081","url":null,"abstract":"<p><strong>Context: </strong>Assessing the overall sustainability of a diet is a challenging undertaking requiring a holistic approach capable of addressing the multicriteria nature of this concept.</p><p><strong>Objective: </strong>The aim was to identify and summarize the multicriteria measures used to assess the sustainability characteristics of diets reported at the individual level by healthy adults.</p><p><strong>Data sources: </strong>Articles were identified via PubMed, Scopus, and Web of Science. The search strategy consisted of key words and MeSH terms, and was concluded in September 2022, covering references in English, Spanish, and Portuguese.</p><p><strong>Data extraction: </strong>This systematic review followed the PRISMA guidelines. The search identified 5663 references, from which 1794 were duplicates. Two reviewers independently screened the titles and abstracts of each of the 3869 records and the full-text of the 144 references selected. Of these, 7 studies met the inclusion criteria.</p><p><strong>Data analysis: </strong>A total of 6 multicriteria measures were identified: 3 different Sustainable Diet Indices, the Quality Environmental Costs of Diet, the Quality Financial Costs of Diet, and the Environmental Impact of Diet. All of these incorporated a health/nutrition dimension, while the environmental and economic dimensions were the second and the third most integrated, respectively. A sociocultural sustainability dimension was included in only 1 of the measures.</p><p><strong>Conclusion: </strong>Despite some methodological concerns in the development and validation process of the identified measures, their inclusion is considered indispensable in assessing the transition towards sustainable diets in future studies.</p><p><strong>Systematic review registration: </strong>PROSPERO registration no. CRD42022358824.</p>","PeriodicalId":19469,"journal":{"name":"Nutrition reviews","volume":null,"pages":null},"PeriodicalIF":5.9,"publicationDate":"2024-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141469741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adaptations in Gastrointestinal Nutrient Absorption and its Determinants During Pregnancy in Monogastric Mammals: A Scoping Review. 单胃哺乳动物妊娠期胃肠道营养吸收的适应性及其决定因素:范围综述。
IF 5.9 2区 医学 Q1 NUTRITION & DIETETICS Pub Date : 2024-06-26 DOI: 10.1093/nutrit/nuae064
Teunis Sebastian Overduin, Amanda J Page, Richard L Young, Kathryn L Gatford

Context: Pregnancy increases nutrient demand, but how nutrient uptake and its determinants adapt to facilitate this is unclear.

Objective: This review aimed to identify and characterize evidence and evidence gaps regarding changes in gastrointestinal nutrient absorption and its determinants during pregnancy in monogastric mammals.

Data sources: A scoping review of peer-reviewed sources was conducted across PubMed, Scopus, Web of Science, Embase, and ProQuest (theses and dissertations) databases.

Data extraction: Data extracted included species, pregnancy stages and outcomes. Where sufficient data for a given outcome was available, relative values were summarized graphically or in tables, to allow comparison across pregnancy stages and/or small intestine regions. Searches identified 26 855 sources, of which only 159 were eligible. Mechanistic studies were largely restricted to rodents, and most compared non- and late-pregnant groups, with fewer studies including early- or mid-pregnant groups.

Data analysis: During pregnancy, there is some evidence for greater capacity for glucose uptake but unchanged amino acid uptake, and good evidence for increased uptake of calcium, iron, and zinc, and slower gastrointestinal passage of nutrients. The available evidence indicates that acute glucose uptake, gastric emptying, and the activities of sucrase, maltase, and lactase do not change during pregnancy. Gaps in the knowledge include the effects of pregnancy on uptake of specific amino acids, lipids, and most minerals and vitamins.

Conclusion: The results indicate that the gastrointestinal tract adapts during pregnancy to facilitate increased nutrient absorption. Additional data is required in order to assess the underlying mechanisms for and impacts on the absorption of many nutrients, as well as to determine the timing of these adaptations.

背景:妊娠会增加营养需求,但营养吸收及其决定因素如何适应这种情况尚不清楚:本综述旨在确定和描述有关单胃哺乳动物妊娠期胃肠道营养吸收及其决定因素变化的证据和证据缺口:在PubMed、Scopus、Web of Science、Embase和ProQuest(学位论文)数据库中对同行评审资料进行了范围审查:提取的数据包括物种、妊娠阶段和结果。如果特定结果有足够的数据,则以图表或表格的形式总结相对值,以便在不同妊娠阶段和/或小肠区域之间进行比较。搜索共发现 26 855 个来源,其中只有 159 个符合条件。机理研究主要局限于啮齿动物,大多数研究比较了非妊娠组和妊娠晚期组,包括妊娠早期或中期组的研究较少:数据分析:有证据表明,妊娠期对葡萄糖的摄取能力增强,但对氨基酸的摄取能力不变;有充分证据表明,对钙、铁和锌的摄取能力增强,但胃肠道通过营养物质的速度减慢。现有证据表明,急性葡萄糖摄取、胃排空以及蔗糖酶、麦芽糖酶和乳糖酶的活性在怀孕期间没有变化。这方面的知识空白包括妊娠对特定氨基酸、脂类以及大多数矿物质和维生素摄取的影响:结论:研究结果表明,胃肠道在怀孕期间会发生适应性变化,以促进营养物质的吸收。需要更多数据来评估许多营养素吸收的潜在机制和影响,以及确定这些适应的时间。
{"title":"Adaptations in Gastrointestinal Nutrient Absorption and its Determinants During Pregnancy in Monogastric Mammals: A Scoping Review.","authors":"Teunis Sebastian Overduin, Amanda J Page, Richard L Young, Kathryn L Gatford","doi":"10.1093/nutrit/nuae064","DOIUrl":"https://doi.org/10.1093/nutrit/nuae064","url":null,"abstract":"<p><strong>Context: </strong>Pregnancy increases nutrient demand, but how nutrient uptake and its determinants adapt to facilitate this is unclear.</p><p><strong>Objective: </strong>This review aimed to identify and characterize evidence and evidence gaps regarding changes in gastrointestinal nutrient absorption and its determinants during pregnancy in monogastric mammals.</p><p><strong>Data sources: </strong>A scoping review of peer-reviewed sources was conducted across PubMed, Scopus, Web of Science, Embase, and ProQuest (theses and dissertations) databases.</p><p><strong>Data extraction: </strong>Data extracted included species, pregnancy stages and outcomes. Where sufficient data for a given outcome was available, relative values were summarized graphically or in tables, to allow comparison across pregnancy stages and/or small intestine regions. Searches identified 26 855 sources, of which only 159 were eligible. Mechanistic studies were largely restricted to rodents, and most compared non- and late-pregnant groups, with fewer studies including early- or mid-pregnant groups.</p><p><strong>Data analysis: </strong>During pregnancy, there is some evidence for greater capacity for glucose uptake but unchanged amino acid uptake, and good evidence for increased uptake of calcium, iron, and zinc, and slower gastrointestinal passage of nutrients. The available evidence indicates that acute glucose uptake, gastric emptying, and the activities of sucrase, maltase, and lactase do not change during pregnancy. Gaps in the knowledge include the effects of pregnancy on uptake of specific amino acids, lipids, and most minerals and vitamins.</p><p><strong>Conclusion: </strong>The results indicate that the gastrointestinal tract adapts during pregnancy to facilitate increased nutrient absorption. Additional data is required in order to assess the underlying mechanisms for and impacts on the absorption of many nutrients, as well as to determine the timing of these adaptations.</p>","PeriodicalId":19469,"journal":{"name":"Nutrition reviews","volume":null,"pages":null},"PeriodicalIF":5.9,"publicationDate":"2024-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141458417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of cinnamon supplementation on metabolic biomarkers in individuals with type 2 diabetes: a systematic review and meta-analysis. 肉桂补充剂对 2 型糖尿病患者代谢生物标志物的影响:系统综述和荟萃分析。
IF 5.9 2区 医学 Q1 Medicine Pub Date : 2024-06-25 DOI: 10.1093/nutrit/nuae058
Suzana Laís de Moura, Bruna Gabrielle Rocha Gomes, Mariana Julião Guilarducci, Olívia Gonçalves Leão Coelho, Nathalia Sernizon Guimarães, Júnia Maria Geraldo Gomes

Context: The global prevalence of type 2 diabetes mellitus (DM2) has been rising significantly over the years. Recent studies have shown beneficial effects of cinnamon on metabolic biomarkers.

Objective: The objective of this review was to assess the effect of cinnamon supplementation on metabolic biomarkers in patients with DM2.

Data sources: The Pubmed/MEDLINE, Cochrane CENTRAL, and Embase databases were searched up to November 10, 2022.

Data extraction: A systematic search was performed for randomized controlled trials (RCTs) evaluating the effect of cinnamon supplementation on metabolic biomarkers, in adults and the elderly with DM2, and comparing the data for a cinnamon intervention group with that for a placebo group or a control group. The main exclusion criteria were studies (1) with other types of diabetes (ie, gestational diabetes or type 1 diabetes), (2) without cinnamon consumption, (3) that did not evaluate metabolic biomarkers, or (4) in vitro and animal studies. Two researchers independently screened 924 records, evaluated full-text studies, extracted data, and appraised their quality. A third researcher was consulted to resolve any discrepancies. The data were pooled using random-effects models and expressed as the weighted mean difference (WMD) with 95% CI. Heterogeneity was assessed using Cochran's Q test and quantified using I2 statistics. Risk of bias was assessed using the Joanna Briggs Institute (JBI) instrument. Sensitivity analysis and the GRADE system were used to assess the robustness and certainty of the findings.

Data analysis: In total, 28 RCTs with a duration ranging from 30 to 120 days and a total enrollment of 3054 patients with DM2 were included. Participants consuming cinnamon showed a significant reduction in fasting blood glucose (FBG) (WMD: -15.26 mg/dL; 95% CI: -22.23 to -8.30; I2 = 88%), postprandial glucose (WMD: -39.22 mg/dL; 95% CI: -63.90 to -14.55; I2 = 100%), HbA1c (WMD: -0.56 mg/dL; 95% CI: -0.99 to -0.13; I2 = 94%), and HOMA-IR (WMD = -0.76, 95% CI: -1.13 to -0.39; I2 = 22%) compared with the control group. An intervention of cinnamon in capsule form reduced FBG (WMD:-18.43 mg/dL, 95% CI: -26.32 to -10.53; I2 = 89%), postprandial glucose (WMD: -44.83 mg/dL, 95% CI: -70.67 to -18.99; I2 = 100%), HbA1c (WMD: -0.56 mg/dL, 95% CI: -1.02 to -0.09; I2 = 94%), total cholesterol (WMD: -13.39 mg/dL; 95% CI: -24.71 to -2.07; I2 = 96%), LDL-C (WMD: -6.49 mg/dL, 95% CI: -12.69 to -0.29; I2 = 92%), and triglycerides (WND: -19.75 mg/dL; 95% CI, -33.71 to -5.80; I2 = 88%). Both doses (≤2 g/day and >2 g/day) reduced FBG and postprandial glucose. Only cinnamon doses of ≤2 g/day reduced HbA1c (WMD: -0.68 mg/dL, 95% CI: -1.16 to -0.1; I2 = 92%), HOMA-IR (WMD: -0.94 mg/dL; 95% CI: -1.21 to -0.67; I2 = 0%), and BMI (WMD: -1.18 kg/m2; 95% CI: -1.97 to -0.39; I2 = 0%).

Conclusion: The data

背景:近年来,全球 2 型糖尿病(DM2)的发病率显著上升。最近的研究表明,肉桂对代谢生物标志物有益:本综述旨在评估肉桂补充剂对 DM2 患者代谢生物标志物的影响:截至2022年11月10日,对Pubmed/MEDLINE、Cochrane CENTRAL和Embase数据库进行了检索:数据提取:系统检索了评估肉桂补充剂对成人和老年 DM2 代谢生物标志物影响的随机对照试验(RCT),并比较了肉桂干预组与安慰剂组或对照组的数据。主要的排除标准是:(1) 涉及其他类型糖尿病(即妊娠糖尿病或 1 型糖尿病)的研究;(2) 未食用肉桂的研究;(3) 未评估代谢生物标志物的研究;或 (4) 体外和动物研究。两名研究人员独立筛选了 924 条记录,评估了研究全文,提取了数据,并对其质量进行了评估。如有任何不一致之处,会咨询第三位研究人员来解决。数据采用随机效应模型进行汇总,并以加权平均差(WMD)和 95% CI 表示。异质性使用 Cochran's Q 检验进行评估,并使用 I2 统计量进行量化。偏倚风险采用乔安娜-布里格斯研究所(JBI)工具进行评估。敏感性分析和 GRADE 系统用于评估研究结果的稳健性和确定性:共纳入了 28 项 RCT 研究,研究持续时间从 30 天到 120 天不等,共招募了 3054 名 DM2 患者。食用肉桂的参与者空腹血糖(FBG)(WMD:-15.26 mg/dL;95% CI:-22.23 至 -8.30;I2 = 88%)、餐后血糖(WMD:-39.22 mg/dL;95% CI:-63.90至-14.55;I2 = 100%)、HbA1c(WMD:-0.56 mg/dL;95% CI:-0.99至-0.13;I2 = 94%)和HOMA-IR(WMD = -0.76,95% CI:-1.13至-0.39;I2 = 22%)。肉桂胶囊干预降低了 FBG(WMD:-18.43 mg/dL,95% CI:-26.32 至 -10.53;I2 = 89%)、餐后血糖(WMD:-44.83 mg/dL,95% CI:-70.67 至 -18.99;I2 = 100%)、HbA1c(WMD:-0.56 mg/dL,95% CI:-1.02 至 -0.09;I2 = 94%)和 HOMA-IR(WMD = -0.76,95% CI:-1.13 至 -0.39;I2 = 22%)。09;I2 = 94%)、总胆固醇(WMD:-13.39 mg/dL;95% CI:-24.71 至 -2.07;I2 = 96%)、低密度脂蛋白胆固醇(WMD:-6.49 mg/dL,95% CI:-12.69 至 -0.29;I2 = 92%)和甘油三酯(WND:-19.75 mg/dL;95% CI,-33.71 至 -5.80;I2 = 88%)。两种剂量(≤2 克/天和大于 2 克/天)都能降低血糖和餐后血糖。只有肉桂≤2克/天的剂量可降低HbA1c(WMD:-0.68毫克/分升,95% CI:-1.16至-0.1;I2 = 92%)、HOMA-IR(WMD:-0.94毫克/分升;95% CI:-1.21至-0.67;I2 = 0%)和BMI(WMD:-1.18千克/平方米;95% CI:-1.97至-0.39;I2 = 0%):数据表明,肉桂能改善血糖和血脂状况并降低 BMI,尤其是对服用肉桂胶囊且剂量≤2 克/天的 DM2 患者:系统综述注册:PROSPERO 注册号CRD42022370332。
{"title":"Effects of cinnamon supplementation on metabolic biomarkers in individuals with type 2 diabetes: a systematic review and meta-analysis.","authors":"Suzana Laís de Moura, Bruna Gabrielle Rocha Gomes, Mariana Julião Guilarducci, Olívia Gonçalves Leão Coelho, Nathalia Sernizon Guimarães, Júnia Maria Geraldo Gomes","doi":"10.1093/nutrit/nuae058","DOIUrl":"https://doi.org/10.1093/nutrit/nuae058","url":null,"abstract":"<p><strong>Context: </strong>The global prevalence of type 2 diabetes mellitus (DM2) has been rising significantly over the years. Recent studies have shown beneficial effects of cinnamon on metabolic biomarkers.</p><p><strong>Objective: </strong>The objective of this review was to assess the effect of cinnamon supplementation on metabolic biomarkers in patients with DM2.</p><p><strong>Data sources: </strong>The Pubmed/MEDLINE, Cochrane CENTRAL, and Embase databases were searched up to November 10, 2022.</p><p><strong>Data extraction: </strong>A systematic search was performed for randomized controlled trials (RCTs) evaluating the effect of cinnamon supplementation on metabolic biomarkers, in adults and the elderly with DM2, and comparing the data for a cinnamon intervention group with that for a placebo group or a control group. The main exclusion criteria were studies (1) with other types of diabetes (ie, gestational diabetes or type 1 diabetes), (2) without cinnamon consumption, (3) that did not evaluate metabolic biomarkers, or (4) in vitro and animal studies. Two researchers independently screened 924 records, evaluated full-text studies, extracted data, and appraised their quality. A third researcher was consulted to resolve any discrepancies. The data were pooled using random-effects models and expressed as the weighted mean difference (WMD) with 95% CI. Heterogeneity was assessed using Cochran's Q test and quantified using I2 statistics. Risk of bias was assessed using the Joanna Briggs Institute (JBI) instrument. Sensitivity analysis and the GRADE system were used to assess the robustness and certainty of the findings.</p><p><strong>Data analysis: </strong>In total, 28 RCTs with a duration ranging from 30 to 120 days and a total enrollment of 3054 patients with DM2 were included. Participants consuming cinnamon showed a significant reduction in fasting blood glucose (FBG) (WMD: -15.26 mg/dL; 95% CI: -22.23 to -8.30; I2 = 88%), postprandial glucose (WMD: -39.22 mg/dL; 95% CI: -63.90 to -14.55; I2 = 100%), HbA1c (WMD: -0.56 mg/dL; 95% CI: -0.99 to -0.13; I2 = 94%), and HOMA-IR (WMD = -0.76, 95% CI: -1.13 to -0.39; I2 = 22%) compared with the control group. An intervention of cinnamon in capsule form reduced FBG (WMD:-18.43 mg/dL, 95% CI: -26.32 to -10.53; I2 = 89%), postprandial glucose (WMD: -44.83 mg/dL, 95% CI: -70.67 to -18.99; I2 = 100%), HbA1c (WMD: -0.56 mg/dL, 95% CI: -1.02 to -0.09; I2 = 94%), total cholesterol (WMD: -13.39 mg/dL; 95% CI: -24.71 to -2.07; I2 = 96%), LDL-C (WMD: -6.49 mg/dL, 95% CI: -12.69 to -0.29; I2 = 92%), and triglycerides (WND: -19.75 mg/dL; 95% CI, -33.71 to -5.80; I2 = 88%). Both doses (≤2 g/day and >2 g/day) reduced FBG and postprandial glucose. Only cinnamon doses of ≤2 g/day reduced HbA1c (WMD: -0.68 mg/dL, 95% CI: -1.16 to -0.1; I2 = 92%), HOMA-IR (WMD: -0.94 mg/dL; 95% CI: -1.21 to -0.67; I2 = 0%), and BMI (WMD: -1.18 kg/m2; 95% CI: -1.97 to -0.39; I2 = 0%).</p><p><strong>Conclusion: </strong>The data ","PeriodicalId":19469,"journal":{"name":"Nutrition reviews","volume":null,"pages":null},"PeriodicalIF":5.9,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141451049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health Benefits of Palm Tocotrienol-Rich Fraction: A Systematic Review of Randomized Controlled Trials. 富含棕榈生育三烯酚馏分的健康益处:随机对照试验的系统回顾。
IF 5.9 2区 医学 Q1 Medicine Pub Date : 2024-06-25 DOI: 10.1093/nutrit/nuae061
Aaron Deming Looi, Uma Devi Palanisamy, Mohanambal Moorthy, Ammu K Radhakrishnan

Context: Vitamin E, a well-known antioxidant with numerous positive effects on human health, encompasses tocotrienol-rich fraction (TRF), a natural variant abundant in palm oil.

Objective: This systematic review analyzed findings from randomized controlled trials published until 2022 to evaluate the health impacts of palm TRF.

Data sources: A literature search was performed in Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, OVID Medline, SCOPUS, and Web of Science from inception until December 2022. Thirty studies involving 2646 patients, including both healthy individuals and those with underlying conditions, were identified.

Results: This review shows palm TRF to be a promising natural supplement against inflammation and lipid peroxidation and that can significantly enhance overall health. Additionally, the study underscores the necessity for further research to ascertain the optimal dosage, formulation, and duration of supplementation, maximizing the potential health advantages.

Conclusion: This systematic review provides evidence supporting the health benefits associated with palm TRF.

Systematic review registration: PROSPERO registration no. CRD42020204070.

背景:维生素 E 是一种众所周知的抗氧化剂,对人体健康有许多积极影响,其中包括富含生育三烯酚的馏分(TRF),这是棕榈油中含量丰富的一种天然变体:本系统综述分析了 2022 年之前发表的随机对照试验结果,以评估棕榈 TRF 对健康的影响:数据来源:从开始到 2022 年 12 月,我们在 Cochrane Central Register of Controlled Trials (CENTRAL)、PubMed、OVID Medline、SCOPUS 和 Web of Science 中进行了文献检索。共发现了 30 项研究,涉及 2646 名患者,包括健康人和有潜在疾病的人:结果:综述显示,棕榈 TRF 是一种很有前景的天然补充剂,可对抗炎症和脂质过氧化反应,并能显著增强整体健康。此外,研究还强调了进一步研究的必要性,以确定最佳剂量、配方和补充时间,最大限度地发挥潜在的健康优势:本系统综述为棕榈 TRF 带来的健康益处提供了证据支持:系统综述注册:PROSPERO 注册号CRD42020204070。
{"title":"Health Benefits of Palm Tocotrienol-Rich Fraction: A Systematic Review of Randomized Controlled Trials.","authors":"Aaron Deming Looi, Uma Devi Palanisamy, Mohanambal Moorthy, Ammu K Radhakrishnan","doi":"10.1093/nutrit/nuae061","DOIUrl":"https://doi.org/10.1093/nutrit/nuae061","url":null,"abstract":"<p><strong>Context: </strong>Vitamin E, a well-known antioxidant with numerous positive effects on human health, encompasses tocotrienol-rich fraction (TRF), a natural variant abundant in palm oil.</p><p><strong>Objective: </strong>This systematic review analyzed findings from randomized controlled trials published until 2022 to evaluate the health impacts of palm TRF.</p><p><strong>Data sources: </strong>A literature search was performed in Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, OVID Medline, SCOPUS, and Web of Science from inception until December 2022. Thirty studies involving 2646 patients, including both healthy individuals and those with underlying conditions, were identified.</p><p><strong>Results: </strong>This review shows palm TRF to be a promising natural supplement against inflammation and lipid peroxidation and that can significantly enhance overall health. Additionally, the study underscores the necessity for further research to ascertain the optimal dosage, formulation, and duration of supplementation, maximizing the potential health advantages.</p><p><strong>Conclusion: </strong>This systematic review provides evidence supporting the health benefits associated with palm TRF.</p><p><strong>Systematic review registration: </strong>PROSPERO registration no. CRD42020204070.</p>","PeriodicalId":19469,"journal":{"name":"Nutrition reviews","volume":null,"pages":null},"PeriodicalIF":5.9,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141446673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Association of Oral Processing Factors and Nutrient Intake in Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis. 居住在社区的老年人口腔加工因素与营养摄入的关系:系统回顾与元分析》。
IF 5.9 2区 医学 Q1 Medicine Pub Date : 2024-06-25 DOI: 10.1093/nutrit/nuae080
Supatchayaporn Nitsuwat, James Webster, Anwesha Sarkar, Janet Cade

Context: Oral health and food oral-processing issues emerge with functional decline in the older adult population, potentially increasing the risk of malnutrition. Impairment of oral health is associated with poorer nutrition status; however, the relationship between oral factors and the intake of each nutrient remains poorly understood.

Objective: The associations between different oral factors and nutrient intakes among community-dwelling older adults were investigated.

Data sources: A literature search from 5 databases (Web of Science, Scopus, Cochrane Library, Ovid [MEDLINE and Embase], and CINAHL) was completed on February 1, 2022. The search was limited to peer-reviewed articles published between the years 2012 and 2022.

Data extraction: Six cross-sectional studies were included in the meta-analysis. Two authors independently completed the data extraction and summarized the study characteristics, factors adjusted for in the statistical analysis, the outcome, and summary statistics of the results.

Data analysis: Meta-analyses showed evidence of a significant association between compromised oral factors (namely, denture status, chewing ability, and the number of teeth) with lower energy (weighted mean difference [WMD], -107 kcal d-1 (95% CI, -132 to -81), protein (WMD, -5.2 g d-1; 95% CI, -6.6 to -3.8), fat (WMD, -4.6 g d-1; 95% CI, -6.7 to -2.6), carbohydrate (WMD, -8.8 g d-1; 95% CI, -13.9 to -3.7), and vitamin C intakes (WMD, -12.9 mg d-1; 95% CI, -16.6 to -9.2) in older adults.

Conclusion: Oral health can be an indicator of compromised daily energy, protein, fat, carbohydrate, and vitamin C intakes in older adults. However, the small sample size of the studies included in this review and the heterogeneity among macronutrient studies should be considered. Because of the lack of studies covering all aspects of food oral processing (eg, salivary flow rate, tongue pressure), the associations between oral processing and nutrient intake were not thoroughly explored.

Systematic review registration: PROSPERO registration no. CRD42022308823.

背景:口腔健康和食物口腔加工问题随着老年人群功能的衰退而出现,可能会增加营养不良的风险。口腔健康受损与较差的营养状况有关;然而,人们对口腔因素与各种营养素摄入量之间的关系仍然知之甚少:调查了社区老年人中不同口腔因素与营养素摄入量之间的关系:2022 年 2 月 1 日完成了对 5 个数据库(Web of Science、Scopus、Cochrane Library、Ovid [MEDLINE 和 Embase] 以及 CINAHL)的文献检索。搜索仅限于 2012 年至 2022 年间发表的经同行评审的文章:荟萃分析共纳入了六项横断面研究。两位作者独立完成了数据提取,并总结了研究特点、统计分析中的调整因素、结果以及结果的汇总统计:元分析表明,口腔受损因素(即义齿状况、咀嚼能力和牙齿数量)与较低能量(加权平均差 [WMD],-107 kcal d-1 (95% CI, -132 to -81))、蛋白质(WMD,-5.老年人的能量(加权平均差 [WMD] -107 千卡/天-1(95% CI,-132 至 -81))、蛋白质(WMD,-5.2 克/天-1;95% CI,-6.6 至 -3.8)、脂肪(WMD,-4.6 克/天-1;95% CI,-6.7 至 -2.6)、碳水化合物(WMD,-8.8 克/天-1;95% CI,-13.9 至 -3.7)和维生素 C 摄入量(WMD,-12.9 毫克/天-1;95% CI,-16.6 至 -9.2)均较低:结论:口腔健康可作为老年人每日能量、蛋白质、脂肪、碳水化合物和维生素 C 摄入量受损的指标。然而,本综述所纳入的研究样本量较小,且各种宏量营养素研究之间存在异质性,这一点应加以考虑。由于缺乏涵盖食物口腔加工所有方面(如唾液流速、舌压)的研究,因此没有深入探讨口腔加工与营养素摄入之间的关联:系统综述注册:PROSPERO 注册号CRD42022308823。
{"title":"The Association of Oral Processing Factors and Nutrient Intake in Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis.","authors":"Supatchayaporn Nitsuwat, James Webster, Anwesha Sarkar, Janet Cade","doi":"10.1093/nutrit/nuae080","DOIUrl":"https://doi.org/10.1093/nutrit/nuae080","url":null,"abstract":"<p><strong>Context: </strong>Oral health and food oral-processing issues emerge with functional decline in the older adult population, potentially increasing the risk of malnutrition. Impairment of oral health is associated with poorer nutrition status; however, the relationship between oral factors and the intake of each nutrient remains poorly understood.</p><p><strong>Objective: </strong>The associations between different oral factors and nutrient intakes among community-dwelling older adults were investigated.</p><p><strong>Data sources: </strong>A literature search from 5 databases (Web of Science, Scopus, Cochrane Library, Ovid [MEDLINE and Embase], and CINAHL) was completed on February 1, 2022. The search was limited to peer-reviewed articles published between the years 2012 and 2022.</p><p><strong>Data extraction: </strong>Six cross-sectional studies were included in the meta-analysis. Two authors independently completed the data extraction and summarized the study characteristics, factors adjusted for in the statistical analysis, the outcome, and summary statistics of the results.</p><p><strong>Data analysis: </strong>Meta-analyses showed evidence of a significant association between compromised oral factors (namely, denture status, chewing ability, and the number of teeth) with lower energy (weighted mean difference [WMD], -107 kcal d-1 (95% CI, -132 to -81), protein (WMD, -5.2 g d-1; 95% CI, -6.6 to -3.8), fat (WMD, -4.6 g d-1; 95% CI, -6.7 to -2.6), carbohydrate (WMD, -8.8 g d-1; 95% CI, -13.9 to -3.7), and vitamin C intakes (WMD, -12.9 mg d-1; 95% CI, -16.6 to -9.2) in older adults.</p><p><strong>Conclusion: </strong>Oral health can be an indicator of compromised daily energy, protein, fat, carbohydrate, and vitamin C intakes in older adults. However, the small sample size of the studies included in this review and the heterogeneity among macronutrient studies should be considered. Because of the lack of studies covering all aspects of food oral processing (eg, salivary flow rate, tongue pressure), the associations between oral processing and nutrient intake were not thoroughly explored.</p><p><strong>Systematic review registration: </strong>PROSPERO registration no. CRD42022308823.</p>","PeriodicalId":19469,"journal":{"name":"Nutrition reviews","volume":null,"pages":null},"PeriodicalIF":5.9,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141446675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Nutrition reviews
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1